Project Details
Description
A Prospective, Randomized, Double-Blind, Phase 3 Study Comparing rhBSSL and Placebo Added to Infant Formula or Pasteurized Breast Milk in Preterm Infants Born Before Week 32 or Gestational Age
Status | Finished |
---|---|
Effective start/end date | 11/25/13 → 4/17/14 |
Funding
- SWEDISH ORPHAN BIOVITRUM AB
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.